BioGaia AB (publ) (BIOGY) Stock Price, News & Analysis

Company Overview

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

Key Stats

• Today's Range: $11.50 to $11.50
• 50-Day Range: $11.50 to $11.50
• 52-Week Range: $8.75 to $12.09
• Volume: N/A
• Average Volume: 1,608 shs
• Market Capitalization: N/A
• P/E Ratio: 2.74
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIOGY Stock Analysis - Frequently Asked Questions

How have BIOGY shares performed this year?

BioGaia AB (publ)'s stock was trading at $9.80 at the start of the year. Since then, BIOGY shares have increased by 17.3% and is now trading at $11.50.
View the best growth stocks for 2024 here.

When did BioGaia AB (publ)'s stock split?

BioGaia AB (publ) shares split before market open on Thursday, May 26th 2022. The 2.5-1 split was announced on Thursday, May 26th 2022. The newly minted shares were payable to shareholders after the closing bell on Thursday, May 26th 2022. An investor that had 100 shares of stock prior to the split would have 250 shares after the split.

How do I buy shares of BioGaia AB (publ)?

Shares of BIOGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BIOGY
• CUSIP: N/A
• CIK: 1572957
• Web: www.biogaia.com
• Phone: (685) 552-9300
• Fax: N/A
• Employees: 200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 2.74
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A